About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Tag Archives: FDA
Happy New Year – and FDA Statement on Government Shutdown
Happy New Year. On a personal note, I have been on a hiatus or shutdown myself to take time while undertaking a move. With that behind me, I am back at it and will be posting again with intermittent content … Continue reading
Posted in Uncategorized
Tagged FDA
Comments Off on Happy New Year – and FDA Statement on Government Shutdown
HHS Proposes Pricing in DTC
In May the Administration released a plan called “America’s Patients First” , a blueprint to lower drug prices and reduce out-of-pocket costs. One of the items contained in that blueprint was to have the manufacturers of medicines include the list … Continue reading
Posted in DTC Advertising, FDA Policy
Tagged DTC, FDA, Pharma, pricing
Comments Off on HHS Proposes Pricing in DTC
Pre-Game Show – What Some of the Important Players Have to Say at the FDA Part 15 Meeting on Social Media
This week a large number of people and entities released their presentations that will be given at the FDA Part 15 Meeting on Social Media and Medical Product Promotion to be held Thursday and Friday, November 12 and 13th at … Continue reading
Posted in Uncategorized
Tagged FDA, Part 15 meeting, Social Media
Comments Off on Pre-Game Show – What Some of the Important Players Have to Say at the FDA Part 15 Meeting on Social Media